Overview

Clinical Trial with Cannabidiol (Kanbis) for Parkinson Disease Symptoms

Status:
RECRUITING
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
Parkinson disease (PD) is a chronic, progressive neurodegenerative disorder characterized by clinical motor and non-motor symptoms. Knowing the potential benefits has led to the use of cannabis as an alternative therapy.
Phase:
PHASE2
Details
Lead Sponsor:
Laboratorio Elea Phoenix S.A.
Treatments:
Cannabidiol
nabiximols